Latest Novavax News & Updates

See the latest news and media coverage for Novavax. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Novavax

Biotechnology company developing vaccines

novavax.com
Headquarters
Gaithersburg, United States
Founded year
1987
Company type
Public company
Number of employees
900–1,000

Last updated

Latest news about Novavax

In short: Novavax reported stronger-than-expected Q1 2026 revenue of $140 million and shifted its strategy toward technology licensing and partnerships.

Company announcements

  • Novavax

    Novavax shares Q1 2026 financial results

    They highlight progress on corporate growth strategy and invite to a live call at 8:30 a.m. ET.

  • Novavax

    Novavax reports Q1 2026 financial results

    Total revenue is $140 million. Announces Pfizer Matrix-M license and multiple MTAs. Reiterates 2026 revenue framework of $230-270 million.

  • Novavax

    Novavax publishes Matrix-M safety data review

    Interview with Jonathan Fix summarizes safety from 66 trials, showing mild reactogenicity and positive benefit-risk profile across populations.

  • Novavax

    Novavax reports Q1 2026 financial results Wednesday

    They share key operational highlights. Registration is available.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Novavax

Track Novavax and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.